MedPath

Safety Study of Continuous Positive Airway Pressure Via a Nasal Mask

Not Applicable
Completed
Conditions
Upper Airway Obstruction
Interventions
Procedure: nasal mask
Registration Number
NCT01524614
Lead Sponsor
Massachusetts General Hospital
Brief Summary

Upper airway obstruction (UAO) is common complication during induction of general anesthesia. The mechanism of UAO during anesthesia has not been well understood. Posterior displacement of soft palate are believed to be the primary contributing factors. The mechanism of UAO during anesthesia share many similarities with obstructive sleep apnea (OSA). Since nasal continuous positive airway pressure (nCPAP) can maintain the airway patent in patients with OSA, the investigators hypothesize that nCPAP during induction of anesthesia will reduce the incidence and severity of UAO.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients,between 18-65 years of age meeting ASA physical status classification I-II requiring general anesthesia for elective surgery who are able to breathe through both their nose and mouth while awake.

Exclusion Criteria
  1. Patients with major cardiovascular disease, respiratory disease, cerebral vascular disease or American Society of Anesthesiologists physical status class III or greater.
  2. Abnormal vital signs on the day of admission for surgery [heart rate (HR, > 100 bpm or < 40 bpm), blood pressure (BP, > 180/100 mmHg or < 90/60 mmHg), room air transcutaneous oxyhemoglobin saturation (SPO2) < 96%] that are not correctable with his or her routine medication or commonly used pre-operative medication.
  3. Unable to open mouth (< 2.5 cm) or unable to breathe through their mouth or nose.
  4. Subjects with a beard, an abnormal facial structure or other factors precluding obtaining a viable face mask fit without air leak. Also, subjects having claustrophobia that can not tolerate the mask.
  5. Any person with an anticipated difficult airway. This will include subjects who require or may require either a fiberoptic intubation or intubation while awake and subjects with known OSA or body mass index (BMI) greater than 35 km/m2.
  6. Gastric-esophageal reflex or a full stomach.
  7. The subject has remained in bed for more than 24 hours.
  8. Neurological symptoms associated with neck extension, a neurological deficit from a previous stroke or spinal cord injury, a recent stroke or transient ischemic attack (TIA) within 2 weeks.
  9. Pregnant women and women less than one month post-partum. Ruling out pregnancy will be conducted by careful history and physical examination as performed routinely prior to surgery. If the history is believed to be unreliable, the patient will be excluded unless a pregnancy test is performed and the result of the test is negative.
  10. Emergency cases and subjects who have not adhered to the ASA NPO (Nil Per Os) guidelines.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nasal mask with PEEPnasal maskNasal mask with PEEP 5, then add PEEP 10
Face mask with no PEEPnasal maskFace mask with PEEP 0 then add PEEP 5, 10
Nasal mask with no PEEPnasal maskNasal mask with PEEP 0, then add PEEP 5, and 10
Face mask with PEEPnasal maskFace mask with PEEP 5, then add PEEP 10
Primary Outcome Measures
NameTimeMethod
expired tidal volumeAverage of one minute after anesthesia induction

Estimated time from induction of anesthesia (drugs given for anesthesia induction) to apnea is one minute.

Secondary Outcome Measures
NameTimeMethod
volume of CO2Average of one minute after anesthesia induction

Estimated time from induction of anesthesia (drugs given for anesthesia induction) to apnea is one minute.

Trial Locations

Locations (1)

Anesthesia and Critical Care, Mass General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath